
|Videos|November 10, 2022
Institutional Perspectives in Neurology, Chaired by Robert T. Naismith, MD
Author(s)NeurologyLive® Staff
Chaired by Robert T. Naismith, MD, of Washington University in St. Louis, the presentations also feature Salim Chahin, MD, MSCE; Anne H. Cross, MD; Gregory F. Wu, MD, PhD; and Matthew R. Brier, MD, PhD. [WATCH TIME: 1 hour, 55 minutes]
Advertisement
NeurologyLive® State of the Science events are short meetings designed to educate neurologists and APPs on the clinical benefits associated with the new science driving new thinking. Our renowned faculty focuses on the most relevant topics to ultimately improve patient care.
TOPICS INCLUDE:
- 02:45 – ECTRIMS Case Presentation: Evidence-Based MS Care — Robert T. Naismith, MD
- 17:25 – Pro: Epstein-Barr Virus Causes Multiple Sclerosis — Anne H. Cross, MD
- 38:30 – Con: Epstein-Barr Virus Causes Multiple Sclerosis — Gregory F. Wu, MD, PhD
- 56:20 – Question & Answer
- 1:08:10 – Choosing a DMT — Salim Chahin, MD, MSCE
- 1:23:55 – Clinical Neuroimaging in MS: More Than Counting Lesions — Matthew R. Brier, MD, PhD
- 1:39:55 – Question & Answer
Advertisement
Latest CME
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Clears Investigational New Drug Application for Remyelinating Agent PTD802 in Multiple Sclerosis
2
Insights on Vibrance-2 Study Results of Alixorexton in Narcolepsy Type 2: Richard K. Bogan, MD, FCCP, FAASM
3
Pipeline Review: Alzheimer Disease Therapies by Mechanism of Action
4
FDA and EMA Accepts Regulatory Applications for Cemdisiran in Generalized Myasthenia Gravis
5
















